Misoprostol Articles
"Vast" reimbursement fraud exposed in France
16 October 2006
FDA advisory on mifepristone
1 August 2005
Alliance Pharma starts Ph III trial for APL202
17 January 2005
Celebrex as good as two drugs for ulcers
6 January 2003
Kaken takes over Cytotec sales in Japan
7 January 2002
Kaken takes over Cytotec sales in Japan
24 December 2001
US mifepristone trial halted as patient dies
11 September 2001
Celltech profits up 28% ex-restructuring
14 March 2001
New indication for Prevacid in USA
7 December 2000
Danco launches Mifiprex in USA
17 November 2000
FDA approves mifepristone abortion pill after years of political battles
29 September 2000
China sees over-supply, low demand for drugs
16 March 2000
US agency seeks more info on mifepristone
24 February 2000
Healthy Third-Quarter Growth For US Drug Majors
22 October 1998
Healthy Second-Quarter Growth For US Drug Firms
29 July 1998
Merged AHP/Monsanto Will Be Top US Drugmaker
15 June 1998
Brazil Warning Over Searle's Misoprostol
4 June 1998
Strong Growth For US Drug Firms In 1997
28 January 1998
Searle's Arthrotec Approved In USA
2 January 1998
Searle Reports Progress With COX-2 Inhibitor
21 October 1996
Yamanouchi To Develop Searle's Celecoxib In Japan
29 April 1996
US Block On Generics "Costing $5 Million A day"
11 March 1996
Mixed Results For Q4 1995 From US Drug Majors
29 January 1996
Many US Biotech Firms See Good 3rd Qtr Sales Growth
13 November 1995
USA Lags Foreign Approvals, PhRMA Demonstrates
16 October 1995
"Only H pylori And NSAIDs Cause Ulcers"
25 September 1995
Delta Pharma starts trials of methotrexate and misoprostol
11 September 1995
Pryor Bill Backs Generics On GATT Patent Term
4 September 1995
Congress Faces Generic Drug Pressure Over GATT
24 July 1995
Cytotec Agreement In Japan
20 March 1995
Abortion Drugs Under FDA Authorization
31 October 1994
Arthrotec Overcomes NSAID Problems
26 September 1994
CYTOTEC PRICE REDUCED
23 May 1994
NEW APPLICATIONS FOR MISOPROSTOL
16 May 1994
US CHEMICAL/DRUG COs SHOW 1st QTR GROWTH
9 May 1994
GYNECOMASTIA WITH ANTIULCERANTS
28 February 1994
ROUND-UP OF 1993'S NEW CHEMICAL ENTITIES
31 January 1994
NEW ARTHROTEC APPROVALS
13 December 1993
MISOPROSTOL PRAISED AT ILAR
26 July 1993
MISOPROSTOL RAISES MIFEGYNE EFFICACY
31 May 1993
NEW PRODUCTS ON JAPAN TARIFF LIST
12 April 1993
ROBERTS ACQUIRES SEARLE PRODUCTS
5 April 1993
SEARLE'S CYTOTEC LAUNCHED IN JAPAN
29 March 1993
1ST LAUNCH OF ARTHROTEC IN UK
8 February 1993
GLAXO AND LILLY'S ULCER DRUGS OFF MEDI-CAL
18 January 1993
ASTRA IS CHEM INSIGHT'S STAR PERFORMER
14 December 1992
SEARLE'S ARTHROTEC APPROVED IN UK
22 June 1992
Showing 1-54 of 54 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
